上海纽脉医疗科技股份有限公司 logo — 上海纽脉医疗科技股份有限公司成立于2015年,是一家致力于经导管...

上海纽脉医疗科技股份有限公司

上海纽脉医疗科技股份有限公司成立于2015年,是一家致力于经导管心脏瓣膜的研发和产业化的高端医疗器械企业,具备完整的自主研发、测试与生产能力,自成立以来已在中国申请170余项发明及实用新型专利申请。

Founded 2015 China Shanghai, China 8 employees Series C Total: $114.00M

General Information

Company Name 上海纽脉医疗科技股份有限公司
Founded Year 2015
Location China Shanghai, China
Employees 8
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with 上海纽脉医疗科技股份有限公司. To contact 上海纽脉医疗科技股份有限公司, visit newmed.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does 上海纽脉医疗科技股份有限公司 compare?

A PDF of 上海纽脉医疗科技股份有限公司 and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting 上海纽脉医疗科技股份有限公司 soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About 上海纽脉医疗科技股份有限公司

Shanghai NewMed Medical Co., Ltd is a Chinese high-tech medical device company specializing in the R&D and industrialization of transcatheter heart valves. Established in 2015, the company has a complete independent R&D, testing, and production capacity and has filed for over 170 inventions and utility model patents in China. NewMed Medical's portfolio includes artificial heart valves and transcatheter implantation systems, offering leading comprehensive innovative solutions for valve interventional therapy. Several of the company's products have been recognized by the National Medical Products Administration of China as innovative medical devices, with some already in the registered clinical stage. The company aims to simplify replacement surgeries and reduce treatment risks, ultimately benefiting the public. NewMed Medical is committed to innovative research and development, collaborating with industry, academia, researchers, and clinicians to bring high-tech medical devices to the market. It has established the NewMed Jidian Innovation Center as an innovation platform and talent training base, integrating the strengths and resources of scientific research institutes, universities, hospitals, and enterprises both domestically and internationally. The company received a Series C investment of $100.00M on 26 March 2021, with participation from OrbiMed, Temasek Holdings, BioTrack Capital, Fortune Venture Capital, Yunfeng, Junzi Touzi, and Zhangkelingyi. NewMed Medical is focused on becoming a leading Chinese high-tech medical device company that aligns with international standards and is dedicated to realizing its vision of "Innovations Improve Life."

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $100.00M 7
OrbiMed, Temasek Holdings +5
26 Mar 2021
Series B $14.00M 1
Shenzhen Fortune Venture Capital
15 Apr 2020
Series B Undisclosed 1
OrbiMed
01 Mar 2020
Series A Undisclosed 1
Tahoe Venture
03 Apr 2018

FAQ About 上海纽脉医疗科技股份有限公司

上海纽脉医疗科技股份有限公司成立于2015年,是一家致力于经导管心脏瓣膜的研发和产业化的高端医疗器械企业,具备完整的自主研发、测试与生产能力,自成立以来已在中国申请170余项发明及实用新型专利申请。
上海纽脉医疗科技股份有限公司 was founded in 2015.
上海纽脉医疗科技股份有限公司 is headquartered in Shanghai, China.
上海纽脉医疗科技股份有限公司 has approximately 8 employees.
上海纽脉医疗科技股份有限公司 has completed 4 funding rounds, raising a total of $114.00M. The latest funding stage is Series C.

We're actively collecting intelligence on 上海纽脉医疗科技股份有限公司.

Source: BounceWatch company record for 上海纽脉医疗科技股份有限公司, https://bouncewatch.com/company/-8, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes